Literature DB >> 15099246

Use of lidocaine patch 5% for chronic low back pain: a report of four cases.

Robert Hines1, Diane Keaney, Michael H Moskowitz, Steven Prakken.   

Abstract

OBJECTIVE: To describe the use of the lidocaine patch 5% (Lidoderm), a targeted peripheral analgesic, in treatment of patients with chronic low back pain.
DESIGN: This retrospective case series examines four patients with pain secondary to spinal degeneration and complications from failed back surgery syndrome, who were prescribed the lidocaine patch as an add-on to their analgesic regimen.
SETTING: Bay Area Pain Medical Associates, Mill Valley, California. PATIENTS: Patients (age range: 33-64 years) were all complicated cases in which multiple analgesics had been prescribed with varying degrees of success. Intervention. Lidocaine patch 5%.
RESULTS: The addition of the lidocaine patch helped relieve varying characteristics of pain, including general pain, shooting pain, burning pain, and allodynia, and had a significant impact on the quality of life of all patients. Some patients were able to reduce or altogether stop some medications. No adverse events were reported from the lidocaine patch.
CONCLUSIONS: Based on our experience with the four cases presented here and with other patients in our clinic, we believe that addition of the lidocaine patch 5% to the analgesic regimen in chronic low back pain may be beneficial. Prospective, controlled clinical trials are planned to further evaluate the efficacy and safety of the lidocaine patch for treatment of chronic low back pain with or without a neuropathic component.

Entities:  

Year:  2002        PMID: 15099246     DOI: 10.1046/j.1526-4637.2002.02051.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  8 in total

1.  Availability of a 5% lidocaine patch used prophylactically for venipuncture- or injection-related pain in children.

Authors:  Cheul-Hong Kim; Ji-Uk Yoon; Hyeon-Jung Lee; Sang-Wook Shin; Ji-Young Yoon; Gyeong-Jo Byeon
Journal:  J Anesth       Date:  2012-03-09       Impact factor: 2.078

2.  [Lidocaine patch for therapy of neuropathic and non-neuropathic pain. A clinical case series of 87 patients].

Authors:  K-U Kern; M Kohl; R T Kiefer
Journal:  Nervenarzt       Date:  2010-12       Impact factor: 1.214

Review 3.  Update on neuropathic pain treatment: ion channel blockers and gabapentinoids.

Authors:  Lucy Chen; Jianren Mao
Journal:  Curr Pain Headache Rep       Date:  2013-09

4.  A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study.

Authors:  Srinivas Nalamachu; R S Crockett; Arnold R Gammaitoni; Errol M Gould
Journal:  MedGenMed       Date:  2006-08-09

5.  Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study.

Authors:  Javeria A Hashmi; Marwan N Baliki; Lejian Huang; Elle L Parks; Mona L Chanda; Thomas Schnitzer; A Vania Apkarian
Journal:  Mol Pain       Date:  2012-04-24       Impact factor: 3.395

6.  Treatment of localized neuropathic pain after disk herniation with 5% lidocaine medicated plaster.

Authors:  Rudolf Likar; Ingo Kager; Michael Obmann; Wolfgang Pipam; Reinhard Sittl
Journal:  Int J Gen Med       Date:  2012-08-17

7.  Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma.

Authors:  Andrew Nicolaou; Bruce Nicholson; Guy Hans; Louis Brasseur
Journal:  J Pain Res       Date:  2011-01-11       Impact factor: 3.133

Review 8.  Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review.

Authors:  Melanie Plested; Sangeeta Budhia; Zahava Gabriel
Journal:  BMC Neurol       Date:  2010-11-19       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.